Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30. (Q39980497)

16 September 2017

Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30. (English)

1 reference

16 September 2017

1 reference

1 reference

7

1 reference

16 September 2017

9

1 reference

16 September 2017

6

C René Leemans

1 reference

16 September 2017

Lars R Perk

1

1 reference

16 September 2017

Marijke Stigter-van Walsum

2

1 reference

16 September 2017

Gerard W M Visser

3

1 reference

16 September 2017

Reina W Kloet

4

1 reference

16 September 2017

Maria J W D Vosjan

5

1 reference

16 September 2017

Raffaella Albano

8

1 reference

16 September 2017

Guus A M S van Dongen

10

1 reference

16 September 2017

language of work or name

1 reference

20 May 2008

1 reference

16 September 2017

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

16 September 2017

35

1 reference

16 September 2017

10

1 reference

16 September 2017

1857-1867

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-008-0774-5

16 September 2017

0 references

cites work

Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN.

1 reference

12 December 2020

(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.

1 reference

12 December 2020

Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.

1 reference

12 December 2020

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

1 reference

12 December 2020

c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase

1 reference

12 December 2020

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

1 reference

12 December 2020

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice

1 reference

12 December 2020

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

1 reference

12 December 2020

Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer

1 reference

12 December 2020

Met, metastasis, motility and more

1 reference

12 December 2020

Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.

1 reference

12 December 2020

Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity

1 reference

12 December 2020

High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy

1 reference

12 December 2020

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies

1 reference

12 December 2020

Rapid blood clearance of immunoglobulin G2a and immunoglobulin G2b in nude mice

1 reference

12 December 2020

Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography.

1 reference

12 December 2020

Scatter-factor and semaphorin receptors: cell signalling for invasive growth

1 reference

12 December 2020

Targeting the c-Met signaling pathway in cancer

1 reference

12 December 2020

A new human cell line (FaDu) from a hypopharyngeal carcinoma.

1 reference

12 December 2020

Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models

1 reference

12 December 2020

Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice

1 reference

12 December 2020

Invasive growth: a MET-driven genetic programme for cancer and stem cells

1 reference

12 December 2020

Synthesis of N-succinimidyl 4-guanidinomethyl-3-[*I]iodobenzoate: a radio-iodination agent for labeling internalizing proteins and peptides

1 reference

12 December 2020

Potential of immuno-positron emission tomography for tumor imaging and immunotherapy planning.

1 reference

12 December 2020

Immuno-PET: a navigator in monoclonal antibody development and applications.

1 reference

12 December 2020

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

12 December 2020

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.

1 reference

12 December 2020

Cancer therapy: can the challenge be MET?

1 reference

12 December 2020

Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek).

1 reference

12 December 2020

C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu

1 reference

12 December 2020

Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner.

1 reference

12 December 2020

Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF.

1 reference

12 December 2020

Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.

1 reference

12 December 2020

10.1007/S00259-008-0774-5

Identifiers

DOI

1 reference

16 September 2017

1 reference